Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21784170rdf:typepubmed:Citationlld:pubmed
pubmed-article:21784170lifeskim:mentionsumls-concept:C0007090lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:21784170lifeskim:mentionsumls-concept:C0047292lld:lifeskim
pubmed-article:21784170pubmed:issue1-2lld:pubmed
pubmed-article:21784170pubmed:dateCreated2011-9-6lld:pubmed
pubmed-article:21784170pubmed:abstractText3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a chlorine disinfection by-product in drinking water, is carcinogenic in rats and genotoxic in mammalian cells in vitro. In the current study, the mechanism of genotoxicity of MX in human lymphoblastoid TK6 cells was investigated by use of the Comet assay, the micronucleus test, and the thymidine kinase (TK) gene-mutation assay. MX induced a concentration-dependent increase in micronuclei and TK mutations. The lowest effective concentrations in the MN test and the TK gene-mutation assay were 37.5?M and 25?M, respectively. In the Comet assay, a slight although not statistically significant increase was observed in the level of DNA damage induced by MX in the concentration range of 25-62.5?M. Molecular analysis of the TK mutants revealed that MX induced primarily point mutations or other small intragenic mutations (61%), while most of the remaining TK mutants (32%) were large deletions at the TK locus, leading to the hemizygous-type loss-of-heterozygosity (LOH) mutations. These findings show that aside from inducing point mutations, MX also generates LOH at the TK locus in human cells and may thus cause the inactivation of tumour-suppressor genes by LOH.lld:pubmed
pubmed-article:21784170pubmed:languageenglld:pubmed
pubmed-article:21784170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:citationSubsetIMlld:pubmed
pubmed-article:21784170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21784170pubmed:statusMEDLINElld:pubmed
pubmed-article:21784170pubmed:monthOctlld:pubmed
pubmed-article:21784170pubmed:issn0027-5107lld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:HonmaMasamits...lld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:HakulinenPasi...lld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:KoyamaNaokiNlld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:YasuiManabuMlld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:YamamotoAyumi...lld:pubmed
pubmed-article:21784170pubmed:authorpubmed-author:KumitaWakakoWlld:pubmed
pubmed-article:21784170pubmed:copyrightInfo2011 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21784170pubmed:issnTypePrintlld:pubmed
pubmed-article:21784170pubmed:day9lld:pubmed
pubmed-article:21784170pubmed:volume725lld:pubmed
pubmed-article:21784170pubmed:ownerNLMlld:pubmed
pubmed-article:21784170pubmed:authorsCompleteYlld:pubmed
pubmed-article:21784170pubmed:pagination43-9lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:meshHeadingpubmed-meshheading:21784170...lld:pubmed
pubmed-article:21784170pubmed:year2011lld:pubmed
pubmed-article:21784170pubmed:articleTitleInduction of TK mutations in human lymphoblastoid TK6 cells by the rat carcinogen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).lld:pubmed
pubmed-article:21784170pubmed:affiliationDivision of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan. pasi.hakulinen@thi.filld:pubmed
pubmed-article:21784170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21784170pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed